Comparison Overview

Sint Maartenskliniek

VS

Memorial Sloan Kettering Cancer Center

Sint Maartenskliniek

Hengstdal 3 Nijmegen, 6522 JV, NL
Last Update: 2025-03-14 (UTC)

Strong

Bij de Sint Maartenskliniek draait alles om de menselijke beweging. Als gespecialiseerd ziekenhuis zijn we in Nederland en Europa toonaangevend in de behandeling van aandoeningen op het gebied van houding en beweging. We staan bekend om onze aanpak van complexe aandoeningen. Maar u kunt ook bij ons terecht voor veelvoorkomende klachten of blessures op het gebied van orthopedie, reumatologie, revalidatiegeneeskunde en pijnbestrijding. We bieden behandelingen en zorg aan op verschillende locaties in Nederland: in Nijmegen, Woerden en Boxmeer.

NAICS: 62
NAICS Definition:
Employees: 1,001-5,000
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Memorial Sloan Kettering Cancer Center

1275 York Avenue, New York, NY, 10065, US
Last Update: 2025-03-04 (UTC)

Excellent

Between 900 and 1000

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the worldโ€™s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.

NAICS: 62
NAICS Definition: Health Care and Social Assistance
Employees: 19,081
Subsidiaries: 5
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/sint-maartenskliniek.jpeg
Sint Maartenskliniek
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/memorial-sloan-kettering-cancer-center.jpeg
Memorial Sloan Kettering Cancer Center
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
Compliance Summary
Sint Maartenskliniek
100%
Compliance Rate
0/4 Standards Verified
Memorial Sloan Kettering Cancer Center
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Sint Maartenskliniek in 2025.

Incidents vs Hospitals and Health Care Industry Average (This Year)

No incidents recorded for Memorial Sloan Kettering Cancer Center in 2025.

Incident History โ€” Sint Maartenskliniek (X = Date, Y = Severity)

Sint Maartenskliniek cyber incidents detection timeline including parent company and subsidiaries

Incident History โ€” Memorial Sloan Kettering Cancer Center (X = Date, Y = Severity)

Memorial Sloan Kettering Cancer Center cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/sint-maartenskliniek.jpeg
Sint Maartenskliniek
Incidents

No Incident

https://images.rankiteo.com/companyimages/memorial-sloan-kettering-cancer-center.jpeg
Memorial Sloan Kettering Cancer Center
Incidents

No Incident

FAQ

Memorial Sloan Kettering Cancer Center company company demonstrates a stronger AI risk posture compared to Sint Maartenskliniek company company, reflecting its advanced AI governance and monitoring frameworks.

Historically, Memorial Sloan Kettering Cancer Center company has disclosed a higher number of cyber incidents compared to Sint Maartenskliniek company.

In the current year, Memorial Sloan Kettering Cancer Center company and Sint Maartenskliniek company have not reported any cyber incidents.

Neither Memorial Sloan Kettering Cancer Center company nor Sint Maartenskliniek company has reported experiencing a ransomware attack publicly.

Neither Memorial Sloan Kettering Cancer Center company nor Sint Maartenskliniek company has reported experiencing a data breach publicly.

Neither Memorial Sloan Kettering Cancer Center company nor Sint Maartenskliniek company has reported experiencing targeted cyberattacks publicly.

Neither Sint Maartenskliniek company nor Memorial Sloan Kettering Cancer Center company has reported experiencing or disclosing vulnerabilities publicly.

Memorial Sloan Kettering Cancer Center company has more subsidiaries worldwide compared to Sint Maartenskliniek company.

Memorial Sloan Kettering Cancer Center company employs more people globally than Sint Maartenskliniek company, reflecting its scale as a Hospitals and Health Care.

Latest Global CVEs (Not Company-Specific)

Description

An issue was discovered in chinabugotech hutool before 5.8.4 allowing attackers to execute arbitrary expressions that lead to arbitrary method invocation and potentially remote code execution (RCE) via the QLExpressEngine class.

Description

A weakness has been identified in JeecgBoot up to 3.8.2. The impacted element is an unknown function of the file /sys/role/exportXls. This manipulation causes improper authorization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in JeecgBoot up to 3.8.2. The affected element is an unknown function of the file /sys/user/exportXls of the component Filter Handler. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in JeecgBoot up to 3.8.2. Impacted is an unknown function of the file /sys/tenant/deleteBatch. The manipulation of the argument ids leads to improper authorization. The attack is possible to be carried out remotely. The complexity of an attack is rather high. The exploitability is considered difficult. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was determined in JeecgBoot up to 3.8.2. This issue affects some unknown processing of the file /api/getDepartUserList. Executing manipulation of the argument departId can lead to improper authorization. The attack can be executed remotely. This attack is characterized by high complexity. The exploitability is assessed as difficult. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X